Jason Lettmann Alx Oncology Holdings Inc (ALXO) insider trading activity
Jason Lettmann is CHIEF EXECUTIVE OFFICER of ALX ONCOLOGY HOLDINGS INC. Currently has a direct ownership of 170,270 shares of ALXO, which is worth approximately $182,188. The most recent transaction as insider was on Feb 19, 2025, when has been sold 2,159 shares (Common Stock) at a price of $1.15 per share, resulting in proceeds of $2,482. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
170K
0.5%
3M change
1.82%
12M change
Total Value Held
$182,188
Jason Lettmann Transaction History
JL
Jason Lettmann
CHIEF EXECUTIVE OFFICER
Menlo Park, CA